Noah Goodman, Chief Officer of Kymera Therapeutics KYMR, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $1.8M. The latest trade was on 06/25.

NG

NG

Noah Goodman

Chief Business Officer

Company

Kymera Therapeutics KYMR

First filing

25/04/09

Trades

18 trades

Buys / sales

0 / 8

12-month net buying

−$1.8M

Last trade

06/25

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	06/25	06/25	5,000 sh2 trades	$114.00avg.	$570,000	−9.1%
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	06/22	06/22	2,500 sh	$99.00	$247,500	−4.7%
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	04/14	04/16	1,347 sh	$90.00	$121,230	−2.6%
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	04/09–04/10	04/10	10,264 sh4 trades	$87.47avg.	$897,785.98	−16.6%